A gene variant of 11β-hydroxysteroid dehydrogenase type 1 is associated with obesity in children

International Journal of Obesity

Volumn 36, Issue 12, 2012, Pages 1558-1563

  Olza, J ^a   Gil Campos, M ^b   Leis, R ^c   Ruperez A I ^a   Tojo, R ^c   Canete R ^b   Gil, A ^a   Aguilera, C M ^a  

^a UNIVERSITY OF GRANADA   (Spain)

^b HOSPITAL UNIVERSITARIO REINA SOFÍA   (Spain)

^c University Hospital of Santiago de Compostela   (Spain)

Author keywords

11 hydroxysteroid dehydrogenase type 1; children; genetic polymorphisms

Indexed keywords

11BETA HYDROXYSTEROID DEHYDROGENASE 1; ADIPONECTIN; BIOLOGICAL MARKER; GAMMA GLUTAMYLTRANSFERASE; GENOMIC DNA; HYDROCORTISONE; PLASMINOGEN ACTIVATOR INHIBITOR 1;

ADOLESCENT; AGE; ALLELE; ANTHROPOMETRY; ARTICLE; BODY MASS; BODY WEIGHT; CARDIOVASCULAR DISEASE; CASE CONTROL STUDY; CHILD; DNA EXTRACTION; FEMALE; GENETIC TRAIT; GENETIC VARIABILITY; GENOTYPE; HUMAN; HYDROCORTISONE BLOOD LEVEL; INFLAMMATION; LIVER INJURY; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE SEQUENCE; OBESITY; PATHOGENESIS; PHENOTYPE; PRESCHOOL CHILD; PRIORITY JOURNAL; PROSPECTIVE STUDY; SINGLE NUCLEOTIDE POLYMORPHISM; WAIST CIRCUMFERENCE;

11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 1; ADOLESCENT; AGE OF ONSET; BIOLOGICAL MARKERS; BODY COMPOSITION; BODY MASS INDEX; CARDIOVASCULAR DISEASES; CASE-CONTROL STUDIES; CHILD; FEMALE; GENE EXPRESSION PROFILING; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; INFLAMMATION; INSULIN RESISTANCE; LIVER; MALE; OBESITY; POLYMORPHISM, SINGLE NUCLEOTIDE; PROSPECTIVE STUDIES; SPAIN;

EID: 84870992253     PISSN: 03070565     EISSN: 14765497     Source Type: Journal    
DOI: 10.1038/ijo.2012.4     Document Type: Article

References (30)

1. Stewart PM, Krozowski ZS. 11 beta-Hydroxysteroid dehydrogenase. Vitam Horm 1999; 57: 249-324.
2. Staab CA, Maser E. 11beta-Hydroxysteroid dehydrogenase type 1 is an important regulator at the interface of obesity and inflammation. J Steroid Biochem Mol Biol 2010; 119: 56-72.
3. Morton NM. Obesity and corticosteroids: 11beta-hydroxysteroid type 1 as a cause and therapeutic target in metabolic disease. Mol Cell Endocrinol 2010;316:154-164.
4. Anagnostis P, Athyros VG, Tziomalos K, Karagiannis A, Mikhailidis DP. Clinical review: the pathogenetic role of cortisol in the metabolic syndrome: a hypothesis. J Clin Endocrinol Metab 2009; 94: 2692-2701.
5. Stewart PM, Boulton A, Kumar S, Clark PMS, Shackleton CHL. Cortisol metabolism in human obesity: impaired cortisone-cortisol conversion in subjects with central adiposity. J Clin Endocrinol Metab 1999; 84: 1022-1027.
6. Rask E, Olsson T, Soderberg S, Andrew R, Livingstone DE, Johnson O, et al. Tissue-specific dysregulation of cortisol metabolism in human obesity. J Clin Endocrinol Metab 2001; 86: 1418-1421.
7. Simonyte K, Rask E, Näslund I, Angelhed JE, Lönn L, Olsson T, et al. Obesity is accompanied by disturbances in peripheral glucocorticoid metabolism and changes in FA recycling. Obesity 2009; 17: 1982-1987.
8. Sandeep TC, Andrew R, Homer NZ, Andrews RC, Smith K, et al. Increased in vivo regeneration of cortisol in adipose tissue in human obesity and effects of the 11beta-hydroxysteroid dehydrogenase type 1 inhibitor carbenoxolone. Diabetes 2005; 54: 872-879.
9. Paulmyer-Lacroix O, Boullu S, Oliver C, Alessi MC, Grino M. Expression of the mRNA coding for 11beta-hydroxysteroid dehydrogenase type 1 in adipose tissue from obese patients: an in situ hybridization study. J Clin Endocrinol Metab 2002; 87: 2701-2705.
10. Paulsen SK, Pedersen SB, Fisker S, Richelsen B. 11Beta-HSD type 1 expression in human adipose tissue: impact of gender, obesity, and fat localization. Obesity 2007; 15: 1954-1960.
11. Mericq V, Medina P, Kakarieka E, Márquez L, Johnson MC, Iñiguez G. Differences in expression and activity of 11beta-hydroxysteroid dehydrogenase type 1 and 2 in human placentas ofterm pregnancies according to birth weightand gender. Eur J Endocrinol 2009; 161: 419-425.
12. Masuzaki H, Paterson J, Shinyama H, Morton NM, Mullins JJ, Seckl JR, et al. A transgenic model of visceral obesity and the metabolic syndrome. Science 2001; 294: 2166-2170.
13. Kotelevtsev Y, Holmes MC, Burchell A, Houston PM, Schmoll D, J Amieson P, et al. 11-Hydroxysteroid dehydrogenase type 1 knockout mice show attenuated glucocorticoid inducible responses and resist hyperglycaemia on obesity or stress. Proc Natl Acad Sci USA 1997; 94: 14924-14929.
14. Morton NM, Holmes MC, Fiévet C, Staels B, Tailleux A, Mullins JJ, et al. Improved lipid and lipoprotein profile, hepatic insulin sensitivity, and glucose tolerance in 11-hydroxysteroid dehydrogenase type 1 null mice. J Biol Chem 2001; 276: 41293-41300.
15. Morton NM, Paterson JM, Masuzaki H, Holmes MC, Staels B, Fievet C, et al. Novel adipose tissue-mediated resistance to diet-induced visceral obesity in 11-hydroxysteroid dehydrogenase type 1-deficient mice. Diabetes 2004; 53: 931-938.
16. Alberts P, Nilsson C, Selen G, Engblom LO, Edling NH, Norling S, et al. Selective inhibition of 11-hydroxysteroid dehydrogenase type 1 improves hepatic insulin sensitivity in hyperglycemic mice strains. Endocrinology 2003; 144: 4755-4762.
17. Nair S, Lee YH, Lindsay RS, Walker BR, Tataranni PA, Bogardus C, et al. 11-Hydroxysteroid dehydrogenase type 1: genetic polymorphisms are associated with type 2 diabetes in Pima Indians independently ofobesity and expression in adipocyte and muscle. Diabetologia 2004; 47: 1088-1095.
18. Franks PW, Knowler WC, Nair S, Koska J, Lee YH, Lindsay RS, et al. Interaction between an 11HSD1 gene variant and birth era modifies the risk of hypertension in Pima Indians. Hypertension 2004; 44: 681-688.
19. Miyamoto Y, Morisaki H, Yamanaka I, Kokubo Y, Masuzaki H, Okayama A, et al. Association study of 11beta-hydroxysteroid dehydrogenase type 1 gene polymorphisms and metabolic syndrome in urban Japanese cohort. Diabetes Res Clin Pract 2009; 85: 32-38.
20. Gelernter-Yaniv L, Feng N, Sebring NG, Hochberg Z, Yanovski JA. Associations between a polymorphism in the 11 beta hydroxysteroid dehydrogenase type I gene and body composition. Int J Obes Relat Metab Disord 2003; 27: 983-986.
21. Cole TJ, Bellizzi MC, Flegal KM, Dietz WH. Establishing a standard definition for child overweight and obesity worldwide: international survey. BMJ 2000; 320: 1240-1243.
22. Gil-Campos M, Ramírez Tortosa MC, Aguilera CM, Cañete R, Gil A. Fasting and postprandial adiponectin alterations anticipate NEFA and TNF-α changes in prepubertal obese children. Nutr Metab Cardiovasc Dis 2011; 21: 62-68.
23. Bruley C, Lyons V, Worsley AG, Wilde MD, Darlington GD, Morton NM, et al. A novel promoter for the 11-hydroxysteroid dehydrogenase type 1 gene is active in lung and is C/EBP independent. Endocrinology 2006; 147: 2879-2885.
24. Staab CA, Stegk JP, Haenisch S, Neiß E, Köbsch K, Ebert B, et al. Analysis of alternative promoter usage in expression of HSD11B1 including the development of a transcript-specific quantitative real-time PCR method. Chem Biol Interact 2011; 191: 104-112.
25. Morales MA, Carvajal CA, Ortiz E, Mosso LM, Artigas RA, Owen GI, et al. Possible pathogenetic role of 11-hydroxysteroid dehydrogenase type 1 (11HSD1) gene polymorphisms in arterial hypertension. Rev Med Chil 2008; 136: 701-710.
26. Draper N, Walker EA, Bujalska IJ, Tomlinson JW, Chalder SM, Arlt W et al. Mutations in the genes encoding 11-hydroxysteroid dehydrogenase type 1 and hexose-6-phosphate dehydrogenase interact to cause cortisone reductase deficiency. Nat Genet 2003; 34: 434-439.
27. Malavasi EL, Kelly V, Nath N, Gambineri A, Dakin RS, Pagotto U, et al. Functional effects of polymorphisms in the human gene encoding 11 beta-hydroxysteroid dehydrogenase type 1 (11 beta-HSD1): a sequence variant at the translation start of 11 beta-HSD1 alters enzyme levels. Endocrinology 2010; 151: 195-202.
28. Wiegand S, Richardt A, Remer T, Wudy SA, Tomlinson JW, Hughes B, et al. Reduced 11beta-hydroxysteroid dehydrogenase type 1 activity in obese boys. Eur J Endocrinol 2007; 157: 319-324.
29. Hellman L, Nakada F, Curti J, Weitzman ED, Kream J, Roffwarg H, et al. Cortisol is secreted episodically by normal man. J Clin Endocrinol Metab 1970; 30: 411-422.
30. Salehi M, Ferenczi A, Zumoff B. Obesity and cortisol status. Horm Metab Res 2005; 37: 193-197.